Iuvando Health
Iuvando Health is recorded as a service provider in 3 clinical trials. Explore its recorded services, study phases and therapeutic areas, with trial-level operational learnings where available.
Clinical trial experience
Showing 3 of 3 trials · Latest update first
PROCEADE PanTumor: A Phase 1b/2, Multicenter, Open Label Study of Anti-CEACAM5 Antibody-Drug Conjugate Precemtabart Tocentecan (M9140) in Participants With Advanced Pancreatic Cancer (Substudy PDAC)
Sponsor Merck Healthcare KGaA
- Start (EU)
- Latest update
- Estimated end
PROCEADE PanTumor: A Phase 1b/2, Multicenter, Open-Label Study of Anti-CEACAM5 Antibody-Drug Conjugate Precemtabart Tocentecan (M9140) in Participants With Advanced Gastric Cancer (Substudy GC)
Sponsor Merck Healthcare KGaA
- Start (EU)
- Latest update
- Estimated end
PROCEADE PanTumor: A Phase 1b/2, Multicenter, Open-Label Study of Anti-CEACAM5 Antibody-Drug Conjugate M9140 in Participants with Advanced Non-Small Cell Lung Cancer (Substudy NSCLC)
Sponsor Merck Healthcare KGaA
- Start (EU)
- Latest update
- Estimated end
Questions about this trial experience
What services are recorded for Iuvando Health?
The 2026-10-09 snapshot links Iuvando Health to 3 distinct CTIS trials. Recorded services include Patient Recruitment Outreach. These are study-specific roles, not a complete or independently verified capability catalogue.
Which therapeutic areas and study phases are recorded for Iuvando Health?
The most frequently recorded therapeutic areas are Solid Tumor Oncology, Gastroenterology, Respiratory. Recorded phases include Phase 1, Phase 2. Use the filters to inspect the supporting studies; missing tags are not evidence of absent experience.
In which countries are trials linked to Iuvando Health conducted?
The linked trials record locations in 5 countries, including Austria, Germany, Spain, France, Italy. These are trial locations, not confirmed office locations or countries where Iuvando Health delivered services.
What can this page tell me about Iuvando Health's trial experience?
Browse 3 distinct trials with recorded roles, sponsor names, available study dates and links to CTIS source records. No trial-level operational findings are recorded in this snapshot. Trial counts and findings do not measure the provider’s performance or establish responsibility for study outcomes.
About this data & company names
One current approved profile per CTIS trial. Services reflect recorded roles, not a complete capability catalogue or a performance ranking. Missing tags mean the information was not recorded. Country tags describe trial locations, not the provider’s service territory.
Start is the reported EU start date; latest update is the CTIS publication date; estimated end is the reported global estimate, which may be in the past. Missing dates are shown as “Not reported”. Operational learnings describe the trial as a whole and do not establish the provider’s responsibility.
Clear service synonyms are grouped; otherwise the source label is retained. Service tags show the recorded roles for each trial. This page groups 1 recorded name variant under Iuvando Health. Legacy brands remain separate unless explicitly matched in the name registry.
View recorded company names
- Iuvando Health GmbH